Answers are grounded in this paper and cite their sources.
Evaluates telepsychiatry's acceptance and use in outpatient care, indicating its viability.
Background: Telepsychiatry expanded rapidly during the COVID-19 pandemic to support continuity of psychiatric care, although its long-term durability following the expiration of pandemic-era policies remains uncertain. This study evaluated long-term utilization of telepsychiatry and patient and clinician acceptability within outpatient practice. Methods: A repeated cross-sectional electronic health record analysis of outpatient psychiatric visits from 2020 to 2025 compared in-person and virtual visit completion and no-show rates across five annual intervals. Telepsychiatry acceptability was evaluated through a patient survey administered in 2021–2022 ( n = 655) and clinician surveys conducted in 2020 ( n = 50) and 2025 ( n = 38). Results: Among 219,007 visits, 44% were in-person and 56% were virtual. The overall no-show rate was 10.46%, with no significant difference between visit types ( p = 0.178). Two intervals demonstrated significant differences: 2021–2022 (virtual = 9.6%, in-person = 11.0%, p < 0.001) and 2024–2025 (virtual = 11.9%, in-person = 10.9%, p < 0.001). The percentage of no-show visits increased as virtual visits decreased (Spearman’s correlation = −0.90, p = 0.037). Most patients agreed that their telepsychiatry visit was as good as in-person (92.4%) and more convenient (97.1%). Provider belief that virtual visits were as effective as in-person decreased from 92.0% in 2020 to 74.3% in 2025 ( p = 0.026). Conclusions: Telepsychiatry utilization remains a substantial component of outpatient care. Comparable no-show rates and high patient satisfaction support telepsychiatry as a viable and acceptable modality, although provider enthusiasm appears to have moderated over time.
No takes yet. Share an insight, caveat, or question.
Heineman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: